Abstract
Drug-induced neutropenia is relatively rare, but it is a severe and unfavorable prognostic complication of pharmacotherapy. One of the main causes of drug-induced neutropenia is the use of cytostatic drugs - an integral part of the treatment of many rheumatological diseases. There are no practical methods for early diagnosis or prevention of drug-induced neutropenia. Successful treatment of this condition is based on the principle of rapid recognition and immediate withdrawal of the drug, the use of which is potentially the cause of the pathology. It is important for practitioners to be alert to the risk of drug-induced neutropenia. It is necessary to raise the awareness of healthcare professionals about the methods of diagnosis, prevention and management of patients with these conditions. The article presents a clinical observation of a patient with reactive arthritis in whom developed drug-induced neutropenia while taking sulfasalazine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
